155 related articles for article (PubMed ID: 18555982)
21. Comparison of the oxime-induced reactivation of rhesus monkey, swine and guinea pig erythrocyte acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity.
Herkert NM; Lallement G; Clarençon D; Thiermann H; Worek F
Toxicology; 2009 Apr; 258(2-3):79-83. PubMed ID: 19428926
[TBL] [Abstract][Full Text] [Related]
22. Peripheral site ligand-oxime conjugates: A novel concept towards reactivation of nerve agent-inhibited human acetylcholinesterase.
de Koning MC; Joosen MJ; Noort D; van Zuylen A; Tromp MC
Bioorg Med Chem; 2011 Jan; 19(1):588-94. PubMed ID: 21112787
[TBL] [Abstract][Full Text] [Related]
23. Cholinesterase reactivation in vivo with a novel bis-oxime optimized by computer-aided design.
Hammond PI; Kern C; Hong F; Kollmeyer TM; Pang YP; Brimijoin S
J Pharmacol Exp Ther; 2003 Oct; 307(1):190-6. PubMed ID: 12893843
[TBL] [Abstract][Full Text] [Related]
24. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned rats.
Kassa J; Jun D; Karasova J; Bajgar J; Kuca K
Chem Biol Interact; 2008 Sep; 175(1-3):425-7. PubMed ID: 18547554
[TBL] [Abstract][Full Text] [Related]
25. Oximes: Reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning.
Kovarik Z; Calić M; Sinko G; Bosak A; Berend S; Vrdoljak AL; Radić B
Chem Biol Interact; 2008 Sep; 175(1-3):173-9. PubMed ID: 18501341
[TBL] [Abstract][Full Text] [Related]
26. New oxime reactivators connected with CH2O(CH2)nOCH2 linker and their reactivation potency for organophosphorus agents-inhibited acetylcholinesterase.
Yang GY; Oh KA; Park NJ; Jung YS
Bioorg Med Chem; 2007 Dec; 15(24):7704-10. PubMed ID: 17869525
[TBL] [Abstract][Full Text] [Related]
27. In vivo oxime administration does not influence Ellman acetylcholinesterase assay results.
Guarisco JA; O'Donnell JC; Skovira JW; McDonough JH; Shih TM
Toxicol Mech Methods; 2009 Sep; 19(6-7):379-85. PubMed ID: 19778238
[TBL] [Abstract][Full Text] [Related]
28. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
29. Kinetic evidence for different mechanisms of acetylcholinesterase inhibition by (1R)- and (1S)-stereoisomers of isomalathion.
Jianmongkol S; Marable BR; Berkman CE; Talley TT; Thompson CM; Richardson RJ
Toxicol Appl Pharmacol; 1999 Feb; 155(1):43-53. PubMed ID: 10036217
[TBL] [Abstract][Full Text] [Related]
30. Effects of oximes on rate of decarbamylation of human red blood cell AChE measured with two different methods.
Eckert S; Eyer P; Melzer M; Thiermann H; Worek F
Biochem Pharmacol; 2008 Apr; 75(7):1561-6. PubMed ID: 18281016
[TBL] [Abstract][Full Text] [Related]
31. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K
Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
[TBL] [Abstract][Full Text] [Related]
32. In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate.
Lorke DE; Hasan MY; Arafat K; Kuca K; Musilek K; Schmitt A; Petroianu GA
J Appl Toxicol; 2008 May; 28(4):422-9. PubMed ID: 18344198
[TBL] [Abstract][Full Text] [Related]
33. Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker--synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.
Musilek K; Holas O; Kuca K; Jun D; Dohnal V; Opletalova V; Dolezal M
Bioorg Med Chem Lett; 2007 Jun; 17(11):3172-6. PubMed ID: 17383875
[TBL] [Abstract][Full Text] [Related]
34. Antidotal treatment of GF-agent intoxication in mice with bispyridinium oximes.
Sevelová L; Kuca K; Krejcová-Kunesová G
Toxicology; 2005 Feb; 207(1):1-6. PubMed ID: 15590116
[TBL] [Abstract][Full Text] [Related]
35. A comparison of reactivating and therapeutic efficacy of newly-developed oximes (K156, K203) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
Kassa J; Karasova JZ; Musilek K; Kuca K
Toxicol Mech Methods; 2009 Jun; 19(5):346-50. PubMed ID: 19778210
[TBL] [Abstract][Full Text] [Related]
36. Retrospective detection of exposure to nerve agents: analysis of phosphofluoridates originating from fluoride-induced reactivation of phosphylated BuChE.
van der Schans MJ; Polhuijs M; van Dijk C; Degenhardt CE; Pleijsier K; Langenberg JP; Benschop HP
Arch Toxicol; 2004 Sep; 78(9):508-24. PubMed ID: 15170525
[TBL] [Abstract][Full Text] [Related]
37. Crystal structures of oxime-bound fenamiphos-acetylcholinesterases: reactivation involving flipping of the His447 ring to form a reactive Glu334-His447-oxime triad.
Hörnberg A; Artursson E; Wärme R; Pang YP; Ekström F
Biochem Pharmacol; 2010 Feb; 79(3):507-15. PubMed ID: 19732756
[TBL] [Abstract][Full Text] [Related]
38. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
[TBL] [Abstract][Full Text] [Related]
39. In vitro oxime-assisted reactivation of paraoxon-inhibited human acetylcholinesterase and butyrylcholinesterase.
Musilova L; Kuca K; Jung YS; Jun D
Clin Toxicol (Phila); 2009 Jul; 47(6):545-50. PubMed ID: 19586353
[TBL] [Abstract][Full Text] [Related]
40. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon.
Petroianu GA; Arafat K; Nurulain SM; Kuca K; Kassa J
J Appl Toxicol; 2007; 27(2):168-75. PubMed ID: 17265452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
